Hisamitsu Pharmaceutical (Germany) Performance
| HPX Stock | EUR 25.20 0.20 0.80% |
Hisamitsu Pharmaceutical has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.5, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hisamitsu Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hisamitsu Pharmaceutical is expected to be smaller as well. Hisamitsu Pharmaceutical right now retains a risk of 2.11%. Please check out Hisamitsu Pharmaceutical sortino ratio, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance , to decide if Hisamitsu Pharmaceutical will be following its current trending patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Hisamitsu Pharmaceutical Co are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Hisamitsu Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 91.4 B | |
| Total Cashflows From Investing Activities | -13.1 B |
Hisamitsu |
Hisamitsu Pharmaceutical Relative Risk vs. Return Landscape
If you would invest 2,400 in Hisamitsu Pharmaceutical Co on September 24, 2024 and sell it today you would earn a total of 120.00 from holding Hisamitsu Pharmaceutical Co or generate 5.0% return on investment over 90 days. Hisamitsu Pharmaceutical Co is currently producing 0.0967% returns and takes up 2.1066% volatility of returns over 90 trading days. Put another way, 18% of traded stocks are less volatile than Hisamitsu, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Hisamitsu Pharmaceutical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hisamitsu Pharmaceutical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hisamitsu Pharmaceutical Co, and traders can use it to determine the average amount a Hisamitsu Pharmaceutical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0459
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | HPX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.11 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Hisamitsu Pharmaceutical is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hisamitsu Pharmaceutical by adding it to a well-diversified portfolio.
Hisamitsu Pharmaceutical Fundamentals Growth
Hisamitsu Stock prices reflect investors' perceptions of the future prospects and financial health of Hisamitsu Pharmaceutical, and Hisamitsu Pharmaceutical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hisamitsu Stock performance.
| Return On Equity | 0.0504 | |||
| Return On Asset | 0.0212 | |||
| Profit Margin | 0.10 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.09 B | |||
| Shares Outstanding | 79.53 M | |||
| Price To Earning | 34.35 X | |||
| Price To Book | 1.14 X | |||
| Price To Sales | 0.02 X | |||
| Revenue | 120.19 B | |||
| EBITDA | 17.3 B | |||
| Cash And Equivalents | 143.16 B | |||
| Total Debt | 219 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 3,393 X | |||
| Cash Flow From Operations | 19.2 B | |||
| Earnings Per Share | 0.96 X | |||
| Total Asset | 302.86 B | |||
About Hisamitsu Pharmaceutical Performance
By analyzing Hisamitsu Pharmaceutical's fundamental ratios, stakeholders can gain valuable insights into Hisamitsu Pharmaceutical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hisamitsu Pharmaceutical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hisamitsu Pharmaceutical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.Things to note about Hisamitsu Pharmaceutical performance evaluation
Checking the ongoing alerts about Hisamitsu Pharmaceutical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hisamitsu Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 26.0% of the company shares are held by company insiders |
- Analyzing Hisamitsu Pharmaceutical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hisamitsu Pharmaceutical's stock is overvalued or undervalued compared to its peers.
- Examining Hisamitsu Pharmaceutical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hisamitsu Pharmaceutical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hisamitsu Pharmaceutical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hisamitsu Pharmaceutical's stock. These opinions can provide insight into Hisamitsu Pharmaceutical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Hisamitsu Stock analysis
When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |